Eye cancer study dispels the theory of nerve activity

Article

Researchers have identified a cell that causes eye cancer, suggesting for the first time that deliberate genetic manipulations may encourage the brain to heal itself.

Researchers have identified a cell that causes eye cancer, suggesting for the first time that deliberate genetic manipulations may encourage the brain to heal itself. The study, published in Cell, has dispelled a long-standing theory about nerve growth and development.

Michael Dyer and colleagues at St Jude Children's Research Hospital, US, found that reducing the activity of the Rb genes in mice retina enables fully differentiated horizontal neurons to multiply while retaining the features of normal horizontal neurons. This demonstrates that retinoblastoma can arise from fully matured horizontal interneurons in the retina and thereby disproves the idea that fully developed nerves cannot multiply like young cells.

Based on these findings, the researchers believe that it may be possible for scientists to induce fully developed neurons to help the brain to heal itself by controlling gene activity in the neurons. This will encourage them to multiply and replace the neurons that were lost as a result of neurodegenerative diseases such as Alzheimer's.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.